RUMATEL 88- morantel tartrate powder

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

MORANTEL TARTRATE (UNII: 5WF7E9QC3F) (MORANTEL - UNII:7NJ031HAX5)

Available from:

Phibro Animal Health

INN (International Name):

MORANTEL TARTRATE

Composition:

MORANTEL TARTRATE 88 g in 0.45 kg

Administration route:

ORAL

Prescription type:

OTC TYPE A MEDICATED ARTICLE

Therapeutic indications:

Cattle: For the removal and control of mature gastrointestinal nematode infections of cattle including stomach worms (Haemonchus spp., Ostertagia spp., Trichostrongylus spp.) , worms of the small intestine (Cooperia spp., Trichostrongylus spp., Nematodirus spp.) , and worms of the large intestine (Oesophagostomum radiatum) .  Goats: For the removal and control of mature gastrointestinal nematode infections of goats including Haemonchus contortus , Ostertagia (Teladorsagia) circumcincta , and Trichostrongylusaxei . For use in the manufacture of medicated beef, dairy, and goat feeds. CAUTION : Certain components of animal feeds, including medicated premixes, possess properties that may be a potential health hazard or a source of personal discomfort to certain individuals who are exposed to them. Human exposure should, therefore, be minimized by observing the general industry standards for occupational health and safety. Precautions such as the following should be considered: dust masks or respirators an

Authorization status:

New Animal Drug Application

Summary of Product characteristics

RUMATEL 88- MORANTEL TARTRATE POWDER
PHIBRO ANIMAL HEALTH
----------
RUMATEL 88
(MORANTEL TARTRATE)
TYPE A MEDICATED ARTICLE
_FOR CATTLE AND GOATS_
ACTIVE DRUG INGREDIENT:
Morantel tartrate . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . 19.4% (88 g/lb)
INDICATIONS FOR USE:
_Cattle: _For the removal and control of mature gastrointestinal
nematode infections of cattle including
stomach worms _(Haemonchus _spp._, Ostertagia _spp._, Trichostrongylus
_spp._)_, worms of the small intestine
_(Cooperia _spp._, Trichostrongylus _spp._, Nematodirus _spp._)_, and
worms of the large intestine
_(Oesophagostomum radiatum)_.
_Goats: _For the removal and control of mature gastrointestinal
nematode infections of goats including
_Haemonchus contortus_, _Ostertagia (Teladorsagia) circumcincta_, and
_Trichostrongylusaxei_.
WARNINGS :
PARASITE RESISTANCE MAY DEVELOP TO ANY DEWORMER, AND HAS BEEN REPORTED
FOR MOST CLASSES OF
DEWORMERS .
TREATMENT WITH A DEWORMER USED IN CONJUNCTION WITH PARASITE MANAGEMENT
PRACTICES APPROPRIATE
TO THE GEOGRAPHIC AREA AND THE ANIMAL(S) TO BE TREATED MAY SLOW THE
DEVELOPMENT OF PARASITE
RES IS TANCE.
FECAL EXAMINATIONS OR OTHER DIAGNOSTIC TESTS AND PARASITE MANAGEMENT
HISTORY SHOULD BE USED TO
DETERMINE IF THE PRODUCT IS APPROPRIATE FOR THE HERD/FLOCK, PRIOR TO
THE USE OF ANY DEWORMER.
FOLLOWING THE USE OF ANY DEWORMER, EFFECTIVENESS OF TREATMENT SHOULD
BE MONITORED (FOR
EXAMPLE, WITH THE USE OF FECAL EGG COUNT REDUCTION TEST OR ANOTHER
APPROPRIATE METHOD).
A DECREASE IN A DRUG’S EFFECTIVENESS OVER TIME AS CALCULATED BY
FECAL EGG COUNT REDUCTION TESTS
MAY INDICATE THE DEVELOPMENT OF RESISTANCE TO THE DEWORMER
ADMINISTERED. YOUR PARASITE
MANAGEMENT PLAN SHOULD BE ADJUSTED ACCORDINGLY BASED ON REGULAR
MONITORING.
CAUTION:
For use in the manufacture of medicated beef, dairy, and goat feeds.
CAUTION: Certain components of animal feeds, including medicated
premixes, possess properties that
may be a potential health hazard or a source of personal discomfort to
certain